Is Sanjay Gupta involved with Neurocept?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Available reporting shows Sanjay Gupta is not involved with Neurocept and has publicly denounced the use of his likeness in AI-generated ads that promote bogus health products (see CNN reporting) [1]. Multiple consumer complaints and independent write-ups allege Neurocept ads use deepfakes of Gupta and other public figures; those reports conclude the endorsements are fake, not authored or approved by Gupta [2] [3].
1. What the record says: Gupta publicly disavows AI ads
CNN published a clear report in which Dr. Sanjay Gupta says scammers are using his likeness in AI deepfake videos and doctored images to sell bogus health cures and fake products; he explicitly speaks out against the practice [1]. That statement from Gupta is the most direct and authoritative public denial in the available material [1].
2. Consumer complaints and watchdog-style reporting point to fake endorsements
Independent sites and consumer complaint posts document Neurocept marketing that features polished video ads presenting Gupta — and other recognizable figures — as endorsers of a “honey recipe” or pill that claims implausible benefits. Those write-ups conclude the videos are part of a bait-and-switch scam and say there is no genuine endorsement from Gupta [2] [3].
3. The specific allegation: deepfake videos and recycled scripts
Reporting describes Neurocept ads as emotional, highly produced videos that present a scripted narrative (the “honey recipe” reversal claim) and then pivot to selling a supplement. The same video template reportedly reappears with different celebrity faces, which is consistent with the mechanics of deepfake-driven ad fraud [2] [3].
4. Evidence quality and limits
The sources available are a mainstream news report (CNN) documenting Gupta’s denunciation [1], a consumer-complaint example recounting an order experience with Neurocept ads [3], and an investigative-sounding blog piece concluding the product is a scam propped up by deepfake ads [2]. These sources document the problem and Gupta’s disavowal but do not include court filings, company statements from Neurocept, or technical forensic reports proving which videos were AI-generated. Those documents are not found in current reporting (available sources do not mention court filings or technical forensics).
5. Why this matters: trust, regulation and financial harm
The combination of hijacked trust (using a high-profile medical reporter’s face) and direct-to-consumer health claims poses public-safety and consumer-protection risks, according to the accounts cited. The CNN piece frames this as a broader phenomenon of scammers leveraging AI to sell bogus health cures; the blog and complaint detail the financial harm to buyers who paid for expensive supplements after seeing such ads [1] [2] [3].
6. Alternative viewpoints and possible counterclaims
Available reporting does not include any verified statement from the makers of Neurocept claiming a legitimate endorsement by Gupta nor any evidence that Gupta ever participated. The Neurocept side of the story is not presented in these sources (available sources do not mention a response from Neurocept). Without that, alternative explanations — such as licensed use, parody, or deceptive resale of old footage — are not documented in the cited material.
7. Practical takeaways for readers
Treat ads that show familiar public figures making extraordinary health claims with skepticism; CNN’s coverage demonstrates that even respected medical journalists can have their image misused [1]. Consumer posts and investigative write-ups advise verifying endorsements directly with the purported endorser or through trustworthy outlets before buying costly products advertised in viral videos [2] [3].
Limitations: this analysis relies only on the three provided items. There may be further reporting, technical forensics, legal actions, or statements by the seller that would add important detail; those are not present in the current sources (available sources do not mention subsequent legal actions or company statements).